ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma

Ling Yan(Southwest Medical University), Baosheng Li(Shandong Tumor Hospital)
Medical Oncology
November 7, 2024
Cited by 22


Related Papers